Eco-Friendly Immunoassay Reagents Featured at AACC 2015
|
By LabMedica International staff writers Posted on 29 Jul 2015 |
|
A pioneering eco-friendly product line of unique, high quality immunoassay reagents that contains no toxic biological or chemical hazards are being exhibited at the 2015 AACC Meeting & Clinical Lab Expo (July 26–30; Atlanta, GA, USA), in Booth 4017.
ECO-TEK, the only commercially available line of environmentally safe immunoassay reagents, will be featured at AACC by Kem-En-Tec Diagnostics A/S (Taastrup, Denmark) and its US distributor, Rainbow Scientific, Inc. (Windsor, CT, USA). Kem-En-Tec Diagnostics, a pioneer of safe and environmentally friendly immunoassay reagents that maintain high standards in quality, sensitivity, and shelf-life, develops ECO-TEK products to eliminate biological and chemical hazards such as BSA, sodium azide, and harmful organic solvents still commonly found in diagnostic assay components.
ECO-TEK reagents reduce the environmental impact of ELISA, blotting, or IHC applications without compromising reliability or stability. Additionally, Kem-En-Tec’s innovative WellChampion Blocking & Protection Buffer eliminates 2 to 3 steps in ELISA plate production, significantly reducing water waste.
Kem-En-Tec Diagnostics technical experts Henrik Christiansen, president & CEO, and Henny Nielsen, Sales & Marketing manager, will be present at the booth, providing visitors a firsthand opportunity to learn about the benefits of ECO-TEK reagents, especially for ELISA kit development. Visitors will also have an opportunity to arrange for free product samples.
“The latest developments from our R&D team provide enhancements in the dynamic range of TMB substrates and phycoerythrin (PE) labeled conjugates,” said Mr. Christensen, “The AACC offers us a unique chance to communicate our ability to meet the requirements of the immunoassay market to our customers and partners.”
“ECO-TEK products reduce environmental pollution from laboratory reagents, including elimination of mercury-containing waste,” said Peter Mousseau, president of Rainbow Scientific, “Visitors to our AACC booth will have the opportunity to speak to technical experts from Kem-En-Tec to learn about eco-friendly solutions for their labs.”
Kem-En-Tec Diagnostic products are registered and listed with the FDA as Device Class 1: General Purpose Reagents.
Related Links:
Rainbow Scientific
Kem-En-Tec Diagnostics
American Association for Clinical Chemistry
 (3) (1).png)
ECO-TEK, the only commercially available line of environmentally safe immunoassay reagents, will be featured at AACC by Kem-En-Tec Diagnostics A/S (Taastrup, Denmark) and its US distributor, Rainbow Scientific, Inc. (Windsor, CT, USA). Kem-En-Tec Diagnostics, a pioneer of safe and environmentally friendly immunoassay reagents that maintain high standards in quality, sensitivity, and shelf-life, develops ECO-TEK products to eliminate biological and chemical hazards such as BSA, sodium azide, and harmful organic solvents still commonly found in diagnostic assay components.
ECO-TEK reagents reduce the environmental impact of ELISA, blotting, or IHC applications without compromising reliability or stability. Additionally, Kem-En-Tec’s innovative WellChampion Blocking & Protection Buffer eliminates 2 to 3 steps in ELISA plate production, significantly reducing water waste.
Kem-En-Tec Diagnostics technical experts Henrik Christiansen, president & CEO, and Henny Nielsen, Sales & Marketing manager, will be present at the booth, providing visitors a firsthand opportunity to learn about the benefits of ECO-TEK reagents, especially for ELISA kit development. Visitors will also have an opportunity to arrange for free product samples.
“The latest developments from our R&D team provide enhancements in the dynamic range of TMB substrates and phycoerythrin (PE) labeled conjugates,” said Mr. Christensen, “The AACC offers us a unique chance to communicate our ability to meet the requirements of the immunoassay market to our customers and partners.”
“ECO-TEK products reduce environmental pollution from laboratory reagents, including elimination of mercury-containing waste,” said Peter Mousseau, president of Rainbow Scientific, “Visitors to our AACC booth will have the opportunity to speak to technical experts from Kem-En-Tec to learn about eco-friendly solutions for their labs.”
Kem-En-Tec Diagnostic products are registered and listed with the FDA as Device Class 1: General Purpose Reagents.
Related Links:
Rainbow Scientific
Kem-En-Tec Diagnostics
American Association for Clinical Chemistry
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Hemodynamic System Monitor
OptoMonitor
Pipette
Accumax Smart Series
Latest AACC 2015 News
- Automated Molecular Diagnostics System Presented at AACC 2015
- Portable Molecular Diagnostics System Unveiled At 2015 AACC
- Expanded Steroid Control Launched at the 2015 AACC Annual Meeting
- Innovative New Technology to Provide Plastic-Exterior Components with Glass Interior, Presented at AACC 2015
- Low Cost Point-of-Care DNA Amplification Test for Chlamydia Infection Demonstrated at the 2015 AACC Annual Meeting
- Inexpensive Multipurpose Point-of-Care Analyzer Unveiled at 2015 AACC Annual Meeting
- State-of-the-Art Automated Laboratory Systems Highlighted at the 2015 AACC Annual Meeting
- Siemens Showcases Multiple New IVD Solutions at AACC 2015
- New HPLC Quadruples Clinical Throughput Capabilities, Displayed at AACC 2015
- Diagnostic Test that Measures Active Renin in Hypertension Displayed at the 2015 AACC Annual Meeting
- Hair Testing May Offer Insights into Asthma-Related Complications in Pregnancy
- Two Newly Developed Tests May Better Diabetes Diagnosis and Monitoring
- CE Marking of Theranostic Monitoring Test Announced at 2015 AACC Annual Meeting
- Ebola Rapid Lateral Flow Test Previewed at the 2015 AACC Annual Meeting
- AACC: Better Quality and Patient-Friendliness Needed in Direct Testing
- Clinical Chemistry Instruments and Reagents Under Scrutiny at the 2015 AACC Annual Meeting
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Technology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read more
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more